Kontour Medical(SH:688314) Xin Lang Cai Jing·2025-09-11 02:15Core Viewpoint - Kangtuo Medical experienced a decline of 5.62% on September 11, with a stock price of 36.43 yuan per share and a total market capitalization of 2.96 billion yuan [1]. Company Overview - Xi'an Kangtuo Medical Technology Co., Ltd. was established on March 14, 2005, and went public on May 18, 2021. The company specializes in the research, production, and sales of three categories of implantable medical devices [1]. - The revenue composition of the company includes: 63.86% from PEEK material neurosurgical products, 22.54% from titanium material neurosurgical products, 10.97% from other products, and 2.62% from supplementary products [1]. Fund Holdings - Dongxing Fund has a significant holding in Kangtuo Medical, with the Dongxing Pharmaceutical Biotechnology Quantitative Selection Mixed A Fund (020830) holding 6,653 shares, representing 3.51% of the fund's net value, making it the sixth-largest holding [2]. - The fund has reported a floating loss of approximately 14,400 yuan as of the latest data [2]. Fund Manager Information - The fund manager of Dongxing Pharmaceutical Biotechnology Quantitative Selection Mixed A Fund is Li Bingwei, who has been in the position for 9 years and 93 days. The total asset size of the fund is 352 million yuan [3]. - During Li Bingwei's tenure, the best fund return was 61.7%, while the worst return was -11.19% [3].